Outcome of Classic Hodgkin Lymphoma Treated with ABVD Regimen- A Single Center Experience
{{output}}
Introduction: Classic Hodgkin lymphoma (cHL) treatment has evolved over recent years, driven by advances in novel agents. In low-income countries with resource constraints, ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazi... ...
